@article{9d62468f2d3a47db935b6a9bb36e7880,
title = "Corrigendum to “Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group”: [Ann Oncol 35 (2024) 588-606, (S092375342400111X), (10.1016/j.annonc.2024.04.005)]",
abstract = "The authors regret that in Table 8, the estimated prevalence of the BRAF V600E mutation in cholangiocarinoma should be 5%, not 50% as reported in the original publication. The corrected Table 8 is given below.",
author = "Mosele, {M. F.} and Westphalen, {C. B.} and A. Stenzinger and F. Barlesi and A. Bayle and I. Bi{\`e}che and J. Bonastre and E. Castro and R. Dienstmann and A. Kr{\"a}mer and Czarnecka, {A. M.} and F. Meric-Bernstam and S. Michiels and R. Miller and N. Normanno and J. Reis-Filho and J. Remon and M. Robson and E. Rouleau and A. Scarpa and C. Serrano and J. Mateo and F. Andr{\'e}",
note = "Publisher Copyright: {\textcopyright} 2024 The Author(s)",
year = "2025",
month = apr,
day = "1",
doi = "10.1016/j.annonc.2024.11.010",
language = "English",
volume = "36",
pages = "472",
journal = "Annals of Oncology",
issn = "0923-7534",
number = "4",
}